Medicare AdvantageCoverageMedium impact
MA07.027h, Autonomic Nervous System Testing
Independence Blue Cross·Neurology, Cardiology, Endocrinology·Medical Policy
Effective date
Mar 4, 2026
We identified it
Jun 19, 2026
Summary
Medicare Advantage policy MA07.027h for Autonomic Nervous System Testing has been reissued with updates effective March 4, 2026. This is a very recent policy change that may affect coverage criteria, billing requirements, or documentation standards for autonomic nervous system testing procedures.
Action Required
By March 4, 2026: Billing team must review the complete updated policy MA07.027h for Autonomic Nervous System Testing to identify specific changes to coverage criteria, prior authorization requirements, or documentation standards. Access the full policy details at the provided URL to determine exact billing and clinical documentation requirements for Medicare Advantage plans.